Opioid Use Disorder Market Share 2022 Growth Challenges, Opportunities and Future Trends 2028

The global Opioid Use Disorder market size is projected to reach US$ 2660 million by 2028, from US$ 1747.7 million in 2021, at a CAGR of 5.7% during 2022-2028. An opioid is a synthetic or natural agent that stimulates opioid receptors and produces opium-like effects. Opioid use disorder is a problematic pattern of opioid use that causes significant impairment or distress.

Data by Type
Buprenorphine
Methadone
Naltrexone

Data by Application
Moderate Pain Treatment
Severe Pain Treatment

Top Major Key Players:
Indivior
Alkermes
Titan Pharmaceuticals
Hikma Pharmaceuticals
Teva Pharmaceuticals
MediciNova
Orexo
Camurus
Omeros

Scope of the Report

The research study analyzes the global Opioid Use Disorder Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Opioid Use Disorder Market Report

1. What was the Opioid Use Disorder Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).
2. What will be the CAGR of Opioid Use Disorder Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Opioid Use Disorder Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.